Fundraising Fox
/Companies
Sign in

NeuroPace

NASDAQ: NPCE

Mountain View, US · Founded 1999 · Delaware corporation · 245 employees on LinkedIn · 3 known investors

Find your way into NeuroPace

Each arrow is one introduction. Sign up to fill in the first one.

84 people can intro you to Joel

Ask Scott Huennekens to introduce you to Joel Becker

You →Scott · together at NeuroPace →Joel

4 people can intro you to Rebecca

Ask Jamie Chen to introduce you to Rebecca Kuhn

You →Jamie · together at HeartPort, Inc. →Rebecca

Sign up to find every way you can get introduced to NeuroPace

  • Your email: who you already know at NeuroPace, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the NeuroPace team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

Digital HealthHardwareHealthtechMedical Devices

Founders & leadership

RKRebecca Kuhn
Rebecca KuhnSenior Strategic Advisor - Finance2025–2026Rebecca Kuhn is Chief Financial Officer of NeuroPace, a medical device company developing brain-responsive neurostimulation treatment for drug-resistant epilepsy. She has led finance and administrative functions across multiple stages of company growth, including IPO preparation and execution, and has experience building finance teams at healthcare organizations.
FFFrank Fischer
Frank FischerExecutive
JBJoel Becker
Joel BeckerPresident and CEOJoel Becker is President, CEO, and Director of NeuroPace, a medical device company developing the RNS System, a brain-responsive neurostimulation platform for treating drug-resistant epilepsy and other neurological disorders.
VBVince Burgess
Vince BurgessBoard Member2017–2020Director at Acutus Medical
RRRenee Ryan
Renee RyanBoard Member (Audit and Compensation Committees)Investor at DigitalDx Ventures
RL
Ray LarkinNamed on SEC filing
GG
Greg GarfieldNamed on SEC filing
MF
Mike FavetNamed on SEC filing
NK
Nael KassarNamed on SEC filing

Board

JSJonathan Silverstein
Jonathan SilversteinBoard directorPartner at OrbiMed
JL
Joseph LacobBoard director

Investors · 3

New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M
OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the S-1 prospectus · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$141.4M disclosed across 2 rounds · 2016–2020

▶$69.4MraisedAug 2020 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nael KassarDirector
  • Rebecca KuhnExecutive Officer
  • Mike FavetExecutive Officer, Director
  • Frank FischerExecutive Officer, Director
  • Greg GarfieldDirector
  • Renee RyanDirector
  • Rishi GuptaDirector
  • Vince BurgessDirector
  • Evan NortonDirector
  • Joseph LacobDirector
Offering amount
$96.4M
Amount sold
$69.4M
Finders' fees
$663.4K
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$72MraisedAug 2017 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rebecca KuhnExecutive Officer
  • Vince BurgessDirector
  • Renee RyanDirector
  • Ray LarkinDirector
  • Jonathan SilversteinDirector
  • Frank FischerExecutive Officer, Director
  • Joseph LacobDirector
  • Greg GarfieldDirector
  • Mike FavetDirector
  • Nael KassarDirector
Offering amount
$80M
Amount sold
$72M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through NeuroPace went on to found or lead other companies.

Patrick BeaulieuPrincipal EngineerFounded MurjBenjamin ShanahanResearch Software EngineerFounded Senra SystemsScott HuennekensBoard MemberFounded Digirad

Related companies · 3

WazeWorld's largest community-based traffic and navigation app.
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Vivian HealthHealthTrust Workforce Solutions is a healthcare staffing and recruitment platform that connects clinical professionals with travel and local contract positions at hospitals and healthcare facilities nationwide. The company provides nurses, technologists, therapists, and other healthcare workers with access to job opportunities while supporting healthcare facilities with workforce solutions.

Companies working in the same space as NeuroPace.

In the news

NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidancefinance.yahoo.com · Aug 2026NeuroPace Raises $67 Million Financing to Support Commercial Expansion of the RNS® System for Refractory Epilepsyneuropace.com · Aug 2020

Frequently asked questions

What does NeuroPace do?
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Who are NeuroPace's investors?
NeuroPace's investors include Accelmed Partners, New Enterprise Associates (NEA), OrbiMed.
How much funding has NeuroPace raised?
NeuroPace has disclosed $141.4M raised across 2 rounds.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, US.